You are here: Industry Insights > Drugs

News List

Global cephalosporin drugs market projected to rise 3.34 percent europeanpharmaceuticalreview
August 20, 2019
The worldwide trade of the cephalosporin class of antibiotics will increase to $14.1 billion by the end of 2025.
Doctors Say New Drugs 'Cured' Two Ebola Patients drugs
August 14, 2019
New drugs cured two Ebola patients in Congo, showing that people can recover from the highly lethal disease if it is diagnosed and treated early, doctors say.
New Ebola Drugs Highly Effective, Might Shorten Outbreak in Africa drugs
August 13, 2019
Two experimental Ebola treatments have worked so well in the Democratic Republic of Congo outbreak that they will be offered to all patients, scientists say.
Pressure BioSciences Inks Contract Services Deal contractpharma
July 26, 2019
Agreement utilizes its BaroFold protein refolding and disaggregation biopharma services.
Gastrointestinal drugs market set to reach $61.6 billion by 2024 europeanpharmaceuticalreview
July 10, 2019
The rise of diseases such as inflammatory bowel syndrome is projected to drive the global gastrointestinal drugs market in the upcoming years.
NHS releases guidance to remove drugs from prescription list europeanpharmaceuticalreview
July 10, 2019
Seven medications have been suggested for removal from prescriptions by the NHS after a public consultation.
Drugs-on-a-coil method could free patients from the burden of taking pills europeanpharmaceuticalreview
July 08, 2019
A research group has designed a pills-on-a-coil system to administer drugs without having to take pills.
E-pharmacies claim in HC they are like Swiggy, only deliver drugs expresspharma
July 05, 2019
E-pharmacies have told the Delhi High Court that they do not require a license for online sale of drugs and prescription medicines as they do not sell them, instead they are only delivering the medications akin to food-delivery app Swiggy.
Implementing global standards to ensure end‑to‑end FMD compliance europeanpharmaceuticalreview
July 05, 2019
Implementing global standards to ensure end‑to‑end FMD compliance.
The impact of counterfeit drugs in south and south-east Asia europeanpharmaceuticalreview
July 05, 2019
Substandard and counterfeit drugs can negatively impact the pharmaceutical industry and patients. Here, we investigate counterfeits in south-east Asia and possible solutions.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page